Fatigue News and Research

RSS

Moderna's bivalent boosters trigger strong antibody response against latest subvariants

Moderna reports the efficacy of a bivalent COVID-19 vaccine booster dose.

14 Nov 2022

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

In addition to the respiratory and gastrointestinal symptoms that accompany COVID-19, many people with the virus experience short- and/or long-term neuropsychiatric symptoms, including loss of smell and taste, and cognitive and attention deficits, known as "brain fog."

14 Nov 2022

What is the post-COVID-19-associated morbidity in German children, adolescents, and adults?

Researchers investigated coronavirus disease 2019 (COVID-19)-associated morbidity in children, adolescents, and adults using healthcare data covering ~46% of the German population.

14 Nov 2022

Study reveals change in symptoms before and after start of dialysis in older patients with kidney failure

In a study published in CJASN that included older adults with kidney failure, symptoms related to their condition worsened in the year before patients started dialysis but stabilized after dialysis initiation.

11 Nov 2022

Analysis reveals highest number of pneumonia deaths in the UK

More people die from pneumonia in the UK than anywhere else in Europe, according to new analysis by leading lung charity, Asthma + Lung UK. Now, the charity is raising awareness of the signs and symptoms of pneumonia, and urging people who are eligible, such as those with severe asthma, pulmonary fibrosis and COPD, to get their one-off pneumonia vaccine.

10 Nov 2022

Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue

In a recent study posted to the medRxiv* server, researchers evaluated non-invasive transcutaneous vagus nerve stimulation [tVNS] as a treatment for long COVID-related chronic fatigue syndrome (CFS).

10 Nov 2022

How long COVID is defined and measured affects prevalence estimation

In a recent study posted to the medRxiv* preprint server, researchers evaluated the prevalence of long coronavirus disease (COVID) symptoms, functional disabilities, symptoms, and pathological alterations among adults and children ≥12 weeks post-acute COVID 2019 (COVID-19).

10 Nov 2022

People of all age groups are at risk of post-COVID-19 syndrome, study says

Following COVID-19 infection, there is significant new onset morbidity in children, adolescents and adults across 13 distinct diagnosis and symptom complexes, according to a new study publishing November 10th in the open access journal PLOS Medicine by Martin Roessler of Technische Universität Dresden, Germany, and colleagues.

10 Nov 2022

NIH-supported researchers launch new study to evaluate intravenous iron treatment for post-pregnancy anemia

Researchers supported by the National Institutes of Health are launching a large study to evaluate a single dose of intravenous iron to treat women experiencing anemia after giving birth.

10 Nov 2022

Research reveals why stem cell transplants are so successful in MS patients

Blood stem cell transplantation is a radical but highly effective therapy for multiple sclerosis. A study led by the University of Zurich has now examined in detail the way in which the treatment curbs the autoimmune disease and how the immune system regenerates afterwards.

10 Nov 2022

Melatonin could be a potential therapy for long-COVID symptoms

A recent review published in the journal Biomolecules discussed the potential uses of melatonin in treating brain fog, and chronic fatigue syndrome or myalgic encephalomyelitis symptoms associated with long coronavirus disease (COVID)

9 Nov 2022

First transfusions of lab-grown blood

Two patients in the United Kingdom received two small doses of lab-grown blood samples as part of the RESTORE trial.

9 Nov 2022

Major life stressors may worsen long COVID symptoms

The death of a loved one, financial or food insecurity, or a newly developed disability were some of the strongest predictors of whether a patient hospitalized for COVID-19 would experience symptoms of long COVID a year later, a new study finds.

9 Nov 2022

Pioneering research identifies a promising treatment approach for myelofibrosis

Pioneering research into the chronic inflammation often seen in certain blood cancers has identified a promising treatment approach for myelofibrosis, a potentially deadly bone marrow cancer.

9 Nov 2022

What are the eye complications associated with monkeypox infection?

A new study describes the association between monkeypox infection and eye complications in humans.

9 Nov 2022

People with long covid face barriers to government disability benefits

When Josephine Cabrera Taveras was infected with covid-19 in spring 2020, she didn't anticipate that the virus would knock her out of work for two years and put her family at risk for eviction.

9 Nov 2022

The direct and indirect effects of COVID-19 on people with type 1 and type 2 diabetes

A recent study published in The Lancet Diabetes & Endocrinology discussed the impact of COVID-19 on individuals with diabetes.

9 Nov 2022

Does vitamin D reduce COVID-19 severity?

A new study examined published studies for a consistent association between vitamin D levels and coronavirus disease 2019 (COVID-19) severity.

8 Nov 2022

Paxlovid antiviral therapy reduces risk of long COVID

In a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].

7 Nov 2022

Multinational consensus to end COVID-19 pandemic

A new study recommended specific actions to end the coronavirus disease 2019 (COVID-19) pandemic.

7 Nov 2022

Fatigue News and Research

Moderna's bivalent boosters trigger strong antibody response against latest subvariants

Older adults suffer from persistent cognitive impairment after recovery from SARS-CoV-2 infection

What is the post-COVID-19-associated morbidity in German children, adolescents, and adults?

Study reveals change in symptoms before and after start of dialysis in older patients with kidney failure

Analysis reveals highest number of pneumonia deaths in the UK

Study evaluates transcutaneous vagus nerve stimulation as treatment for long COVID-chronic fatigue

How long COVID is defined and measured affects prevalence estimation

People of all age groups are at risk of post-COVID-19 syndrome, study says

NIH-supported researchers launch new study to evaluate intravenous iron treatment for post-pregnancy anemia

Research reveals why stem cell transplants are so successful in MS patients

Melatonin could be a potential therapy for long-COVID symptoms

First transfusions of lab-grown blood

Major life stressors may worsen long COVID symptoms

Pioneering research identifies a promising treatment approach for myelofibrosis

What are the eye complications associated with monkeypox infection?

People with long covid face barriers to government disability benefits

The direct and indirect effects of COVID-19 on people with type 1 and type 2 diabetes

Does vitamin D reduce COVID-19 severity?

Paxlovid antiviral therapy reduces risk of long COVID

Multinational consensus to end COVID-19 pandemic

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News